Search results for "malaria"
Selected Filters:
Getting ready for In Vitro Diagnostic Regulation (IVDR)
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
4 expert webinars you won't want to miss
Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research
Fundamentals of advanced spectral cell analysis using the ID7000™ system
Watch this on-demand webinar for expert insight into spectral cell analysis and how it may be used to generate parametric data
IONTAS identifies novel SARS-CoV-2 neutralizing antibodies
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
Thermo Fisher Scientific, Mayo Clinic partner on new diagnostic tools
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
Merck accelerates European expansion plans for single-use products critical to manufacturing vaccines
A response to the unprecedented global demand for key scientific resources
IDT launches rhAmpSeq™ CRISPR analysis system
New system provides end-to-end solution for researchers to validate specificity of CRISPR and other genome editing projects
New AOC-30 Series automatic sample injection system: Extending the need for next-generation laboratories
The new system supports remote operability for laboratory processes
Agilent Cary Eclipse fluorescence spectrophotometer brochure
Breaking down barriers: Willing precision omics to life
Dr. John Wilson explains how ProtiFi set out to develop solutions to all the problems preventing omics from delivering real clinical impact
Chance to win a new CO2 incubator with NuAire
Just share a photo of your current incubator to enter the competition
Roche has launched new high-throughput configurations for cobas pro integrated solutions to increase testing efficiency
By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased
New phase III data shows investigational antibody cocktail reduced hospitalization or death by 70% in non-hospitalized patients with COVID-19
Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days
FDA has approved MSD's KEYTRUDA (pembrolizumab) plus platinum- and fluoropyrimidine-based chemotherapy
Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma